Stevanato Group (NYSE:STVN) Shares Up 3.9% – Here’s Why

Stevanato Group S.p.A. (NYSE:STVN) rose 3.9% during mid-day trading on Tuesday . The company traded as high as €21.39 ($23.25) and last traded at €21.39 ($23.25). Approximately 126,061 shares were traded during trading, a decline of 64% from the average daily volume of 350,071 shares. The stock had previously closed at €20.58 ($22.37).

Analyst Ratings Changes

A number of research firms have recently commented on STVN. Bank of America boosted their price objective on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, December 13th. William Blair reiterated an “outperform” rating on shares of Stevanato Group in a research report on Friday, March 7th. Morgan Stanley restated an “equal weight” rating and set a $23.00 price objective (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. UBS Group dropped their target price on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a report on Friday, March 7th. Finally, Wolfe Research initiated coverage on shares of Stevanato Group in a report on Friday, December 13th. They set an “outperform” rating and a $28.00 target price for the company. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of €27.75 ($30.16).

Stevanato Group Trading Up 4.0 %

The company’s 50 day simple moving average is €21.16 and its two-hundred day simple moving average is €20.58. The stock has a market cap of $6.48 billion, a price-to-earnings ratio of 45.53, a price-to-earnings-growth ratio of 7.18 and a beta of 0.60. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share for the quarter, hitting analysts’ consensus estimates of €0.20 ($0.22). The company had revenue of €352.68 million during the quarter, compared to the consensus estimate of €346.26 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. Research analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Institutional Trading of Stevanato Group

Large investors have recently added to or reduced their stakes in the business. Van Berkom & Associates Inc. acquired a new stake in shares of Stevanato Group in the 4th quarter valued at $39,000. Johnson Financial Group Inc. bought a new position in Stevanato Group during the fourth quarter valued at about $41,000. Wells Fargo & Company MN lifted its position in shares of Stevanato Group by 680.3% in the fourth quarter. Wells Fargo & Company MN now owns 3,246 shares of the company’s stock worth $71,000 after buying an additional 2,830 shares during the last quarter. PNC Financial Services Group Inc. boosted its stake in shares of Stevanato Group by 1,457.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company’s stock worth $123,000 after acquiring an additional 5,291 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in shares of Stevanato Group by 202.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company’s stock worth $162,000 after acquiring an additional 4,965 shares in the last quarter.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.